The latest closing stock price for Unicycive Therapeutics as of May 30, 2025 is 0.59.
An investor who bought $1,000 worth of Unicycive Therapeutics stock at the IPO in 2021 would have $-883 today, roughly -1 times their original investment - a -41.49% compound annual growth rate over 4 years.
The all-time high Unicycive Therapeutics stock closing price was 5.85 on July 13, 2021.
The Unicycive Therapeutics 52-week high stock price is 0.96, which is 62.7% above the current share price.
The Unicycive Therapeutics 52-week low stock price is 0.20, which is 66.1% below the current share price.
The average Unicycive Therapeutics stock price for the last 52 weeks is 0.54.
An investor who bought $1,000 worth of Unicycive Therapeutics stock at the IPO in 2021 would have $-883 today, roughly -1 times their original investment - a -41.49% compound annual growth rate over 4 years.
The all-time high Unicycive Therapeutics stock closing price was 5.85 on July 13, 2021.
The Unicycive Therapeutics 52-week high stock price is 0.96, which is 62.7% above the current share price.
The Unicycive Therapeutics 52-week low stock price is 0.20, which is 66.1% below the current share price.
The average Unicycive Therapeutics stock price for the last 52 weeks is 0.54.